Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:businessModel |
gptkb:public_company
|
| gptkbp:collaboratedWith |
gptkb:Merck_&_Co.
|
| gptkbp:developedBy |
gptkb:molnupiravir
gptkb:EIDD-2801 |
| gptkbp:focusesOn |
infectious diseases
|
| gptkbp:foundedYear |
2016
|
| gptkbp:founder |
Wayne Holman
Wendy Holman |
| gptkbp:headquartersLocation |
gptkb:Miami,_Florida,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Ridgeback Biotherapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
gptkb:molnupiravir
|
| gptkbp:product |
antiviral therapeutics
|
| gptkbp:website |
https://www.ridgebackbio.com/
|
| gptkbp:bfsParent |
gptkb:默沙东
|
| gptkbp:bfsLayer |
5
|